[Statins and the risk of dementia].

By C. Schweiger. Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2001

940 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/3fe32772b9d7212c759162a2155525eca624a477

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Citations in the corpus

Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention (2009, background): “Several cross-sectional and case-control studies have reported that statin users have a considerable lower prevalence of AD.(94,95) While the follow-up data from the Rotterdam Study showed that use of statins was associated with a lower risk of AD independent of lipophilicity of statins,(96) other p”
Oleuropein in Olive and its Pharmacological Effects (2010, background): “The circumstantial evidence that cholesterol-related interventions can alter Aβ deposition [84, 85] suggests that oleuropein might be promising in the management of AD.”
Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.R400004-JLR200 (2004, background): “ment of older individuals with pharmaceutical agents that decreased the plasma cholesterol concentration appeared to be associated with a lower incidence of such dementias (11, 12).”
Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts (2003, background): “Interestingly, two independent retrospective studies reported a strong decrease in the incidence of AD and dementia in patients treated with 3-hydroxy-3-methylglutaryl– coenzyme A reductase inhibitors (Jick et al., 2000; Wolozin et al., 2000).”
Alzheimer's disease: the cholesterol connection (2003, background): “The interaction between Alzheimer amyloid beta(1-40) peptide and ganglioside GM1-containing membranes.”
Aggregation of vascular risk factors and risk of incident Alzheimer disease (2005, background): “Diabetes (6–8), hyperlipidemia (9), hypertension (10), heart disease (11), smoking (12,13), homocysteine (14), and obesity (15) are associated with a higher risk of AD.”
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline (2007, background): “Statins used for the treatment of hypercholesterolaemia were found to decrease the prevalence of AD in two studies with retrospective or cross-sectional analysis [187,188].”
Linking Lipids to Alzheimer’s Disease: Cholesterol and Beyond (2011, background): “Retrospective case control studies suggest that statins reduce the risk of developing A”
Lipid Rafts in the Maintenance of Synapses, Dendritic Spines, and Surface AMPA Receptor Stability (2003, background): “, 1995), as are elevated serum cholesterol levels (Notkola et al., 1998; Jick et al., 2000).”